Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00622622
What this trial is testing

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 21
Early research (Phase 1)Study completedNCT00614653
What this trial is testing

Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 17
Early research (Phase 1)Study completedNCT01351103
What this trial is testing

LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Who this might be right for
Pancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more
Novartis Pharmaceuticals 185
Early research (Phase 1)Study completedNCT00096707
What this trial is testing

Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors

Who this might be right for
Lung CancerBreast CancerPancreatic Cancer+2 more
Threshold Pharmaceuticals 50
Early research (Phase 1)Ended earlyNCT00783172
What this trial is testing

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Milton S. Hershey Medical Center 4
Testing effectiveness (Phase 2)UnknownNCT02758587
What this trial is testing

Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)

Who this might be right for
Carcinoma, Non-small-cell LungMesotheliomaPancreatic Neoplasms
NHS Greater Glasgow and Clyde 59
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Early research (Phase 1)Study completedNCT00003411
What this trial is testing

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
University of Pittsburgh
Early research (Phase 1)Ended earlyNCT01025882
What this trial is testing

Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Texas Southwestern Medical Center 5
Early research (Phase 1)Study completedNCT02639026
What this trial is testing

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Who this might be right for
MetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more
Abramson Cancer Center at Penn Medicine 53
Early research (Phase 1)Study completedNCT00620295
What this trial is testing

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
Masonic Cancer Center, University of Minnesota 17
Early research (Phase 1)Looking for participantsNCT05740956
What this trial is testing

Hansoh (HS)-10502 in Patients With Advanced Solid Tumors

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+2 more
Jiangsu Hansoh Pharmaceutical Co., Ltd. 318
Early research (Phase 1)Ended earlyNCT01198522
What this trial is testing

Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection
Philogen S.p.A. 28
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Early research (Phase 1)Active Not RecruitingNCT02381561
What this trial is testing

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Who this might be right for
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7+38 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00707278
What this trial is testing

Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma

Who this might be right for
CancerPancreas
University of Utah 13
Testing effectiveness (Phase 2)Ended earlyNCT01834235
What this trial is testing

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Precision Biologics, Inc 81
Testing effectiveness (Phase 2)Study completedNCT04257448
What this trial is testing

Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic AdenocarcinomaPancreatic Ductal Adenocarcinoma
GWT-TUD GmbH 75
Early research (Phase 1)Looking for participantsNCT05779917
What this trial is testing

Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

Who this might be right for
Pancreas CancerCAR-T Cell TherapyMesothelin+1 more
Second Affiliated Hospital of Guangzhou Medical University 30
Next Page